Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
暂无分享,去创建一个
W. Frankel | A. de la Chapelle | H. Nakagawa | Janet C Lockman | T. Prior | J. Westman | H. Hampel | J. Panescu | M. Arnold | K. Khanduja | I. Comeras | P. Kuebler | D. Fix | E. Martin | Kaisa Sotamaa
[1] Hidewaki Nakagawa,et al. Mismatch Repair Gene PMS2 , 2004, Cancer Research.
[2] Sudhir Srivastava,et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.
[3] C. Behling,et al. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. , 2004, Gastroenterology.
[4] H. Nakagawa,et al. Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques , 2003, Human mutation.
[5] Daniel J Sargent,et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. , 2003, The New England journal of medicine.
[6] P. Goodfellow,et al. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] D. Zwijnenburg,et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. , 2002, Nucleic acids research.
[8] Daniel J Sargent,et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] P. Peltomäki,et al. Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M. Leppert,et al. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. , 2001, Gastroenterology.
[11] D. Schaid,et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. , 2001, American journal of human genetics.
[12] L. Aaltonen,et al. Age-related hypermethylation of the 5' region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. , 2001, Cancer research.
[13] R. Chadwick,et al. Hereditary and somatic DNA mismatch repair gene mutations in sporadic endometrial carcinoma , 2001, Journal of Medical Genetics.
[14] S. Antonarakis,et al. Nomenclature for the description of human sequence variations , 2001, Human Genetics.
[15] R. Chadwick,et al. Recurrent germline mutation in MSH2arises frequently de novo , 2000, Journal of medical genetics.
[16] D. Glavač,et al. Novel mutations in the homogentisate- 1,2-dioxygenase gene identified in Slovak patients with alkaptonuria , 2000, Journal of medical genetics.
[17] L. Aaltonen,et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] L. Aaltonen,et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. , 2000, Gastroenterology.
[19] P. Lynch. Clinical challenges in management of familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer , 1999, Cancer.
[20] H T Lynch,et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.
[21] G. Deng,et al. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. , 1999, Cancer research.
[22] A. Beaudet. Making Genomic Medicine a Reality , 1999 .
[23] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[24] J. Herman,et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[25] L. Aaltonen,et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. , 1998, The New England journal of medicine.
[26] C R Scriver,et al. Proof of “disease causing” mutation , 1998, Human mutation.
[27] C. Boland,et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. , 1997, Journal of the National Cancer Institute.
[28] A. Motulsky. Screening for genetic diseases. , 1997, The New England journal of medicine.
[29] E. Thomson,et al. Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to Cancer: I. Hereditary Nonpolyposis Colon Cancer , 1997 .
[30] E. Thomson,et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. , 1997, JAMA.
[31] M. Loda,et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. , 1997, Cancer research.
[32] J. Mecklin,et al. The International Collaborative Group on HNPCC. , 1994, Anticancer research.
[33] H T Lynch,et al. Hereditary Nonpolyposis Colorectal Cancer Patients Replication Errors in Benign and Malignant Tumors from , 2006 .
[34] K. Kinzler,et al. Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.
[35] A. de la Chapelle,et al. Hereditary Colorectal Cancer , 2010 .